Sec15A inhibitors belong to a specific category of chemical compounds designed to target and inhibit the activity of the Sec15A protein, a critical component of the exocyst complex. The exocyst complex is a highly conserved protein complex found in eukaryotic cells, and it plays a central role in regulating vesicle trafficking and secretion processes. Sec15A is one of the eight subunits of the exocyst complex, and its primary function is to tether vesicles to specific membrane sites in preparation for their fusion with the plasma membrane. This tethering process is essential for the accurate delivery of membrane-bound cargo to the cell surface, facilitating processes like membrane expansion, secretion of proteins, and cell growth. Inhibitors of Sec15A are primarily developed for research purposes, serving as crucial tools for scientists and researchers to investigate the molecular mechanisms and functions associated with this protein in the context of intracellular transport and cellular biology.
Sec15A inhibitors are typically composed of small molecules or chemical compounds specifically designed to interact with the Sec15A protein, disrupting its normal function in vesicle tethering and exocytosis. By inhibiting Sec15A, these compounds can potentially interfere with the precise targeting of vesicles to their intended destination, leading to alterations in intracellular transport and secretion processes. Researchers use Sec15A inhibitors in laboratory settings to manipulate the activity of this protein and study its roles in various cellular processes, particularly those related to vesicle trafficking, membrane dynamics, and cell growth. These inhibitors provide valuable insights into the molecular mechanisms by which Sec15A mediates vesicle tethering and contribute to a deeper understanding of its significance in the context of cellular biology. While Sec15A inhibitors may have broader implications, their primary purpose is to assist scientists in deciphering the intricacies of Sec15A-mediated exocytosis and its impact on intracellular transport.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially decreasing overall Sec15A protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, which could reduce transcription of the Sec15A gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that affects protein synthesis, possibly downregulating Sec15A expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms DNA adducts, leading to disruptions in DNA transcription and potentially affecting Sec15A levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER to Golgi transport, which may indirectly influence Sec15A expression and function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts Golgi function, potentially impacting Sec15A expression as a response to altered vesicular transport. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, affecting protein folding and stability, possibly influencing Sec15A levels. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis, which could decrease Sec15A protein levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that may cause accumulation of misfolded proteins, possibly affecting Sec15A stability. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Alkalizes lysosomes and autophagosomes, which could indirectly affect the degradation pathways of Sec15A. | ||||||